Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct 24;396(10259):1308-1309.
doi: 10.1016/S0140-6736(20)32006-7. Epub 2020 Sep 25.

SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA

Barnaby Flower  1 , Christina Atchison  2
Affiliations
Comment

SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA

Barnaby Flower et al. Lancet. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Rosenberg ES, Tesoriero JM, Rosenthal EM. Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York. Ann Epidemiol. 2020;48:23–29. - PMC - PubMed
    1. Sood N, Simon P, Ebner P. Seroprevalence of SARS-CoV-2–specific antibodies among adults in Los Angeles County, California, on April 10–11, 2020. JAMA. 2020;323:2425–2427. - PMC - PubMed
    1. Liu T, Wu S, Tao H, Zeng G, Zhou F, Fangjian Guo XW. Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan—implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2. medRxiv. 2020 doi: 10.1101/2020.06.13.20130252. published online June 16. (preprint) - DOI
    1. Silveira MF, Barros AJD, Horta BL. Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil. Nat Med. 2020;26:1196–1199. - PubMed
    1. Ward H, Atchison C, Whitaker M. Antibody prevalence for SARS-CoV-2 following the peak of the pandemic in England: REACT2 study in 100,000 adults. medRxiv. 2020 doi: 10.1101/2020.08.12.20173690. published online Aug 21. (preprint) - DOI

Substances